Terug
Dagbereik
€ 7,38
€ 7,71
52-Weeksbereik
€ 4,55
€ 9,73
Volume
330.238
50D / 200D Gem.
€ 7,56
/
€ 7,81
Vorige Slotkoers
€ 7,20
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4,2 | 0,4 |
| P/B | 9,1 | 2,9 |
| ROE % | -143,5 | 3,8 |
| Net Margin % | -444,1 | 3,9 |
| Rev Growth 5Y % | 20,9 | 10,0 |
| D/E | 1,3 | 0,2 |
Koersdoel Analisten
Hold
€ 18,00
+135.3%
Low: € 16,00
High: € 20,00
Forward WPA
-€ 1,13
Omzet Sch.
120 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,60
-€ 0,15 – € 1,11
|
360 M | 1 |
| FY2028 |
-€ 0,54
-€ 1,46 – € 0,80
|
210 M | 3 |
| FY2027 |
-€ 0,82
-€ 2,14 – € 0,36
|
150 M | 3 |
Belangrijkste Punten
Revenue grew 20,93% annually over 5 years — strong growth
Negative free cash flow of -109,45M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 116,49%
Groei
Revenue Growth (5Y)
20,93%
Revenue (1Y)137,42%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-143,48%
ROIC-80,69%
Net Margin-444,10%
Op. Margin-493,44%
Veiligheid
Debt / Equity
1,25
Current Ratio2,03
Interest Coverage-12,37
Waardering
P/E Ratio
-4,17
P/B Ratio9,08
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 137,42% | Revenue Growth (3Y) | 44,58% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 20,93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 33,28M | Net Income (TTM) | -147,79M |
| ROE | -143,48% | ROA | -54,79% |
| Gross Margin | 28,51% | Operating Margin | -493,44% |
| Net Margin | -444,10% | Free Cash Flow (TTM) | -109,45M |
| ROIC | -80,69% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,25 | Current Ratio | 2,03 |
| Interest Coverage | -12,37 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,17 | P/B Ratio | 9,08 |
| P/S Ratio | 18,50 | PEG Ratio | -0,07 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 615,76M | Enterprise Value | 596,89M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 33,28M | 14,02M | 15,92M | 37,70M | 15,56M |
| Net Income | -147,79M | -84,03M | -129,62M | -79,56M | -57,99M |
| EPS (Diluted) | -2,12 | -1,49 | -3,16 | -1,63 | -1,43 |
| Gross Profit | 9,49M | 14,02M | 15,92M | 37,70M | 15,56M |
| Operating Income | -164,21M | -137,06M | -116,36M | -72,76M | -62,55M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 269,75M | 326,74M | 318,24M | 320,16M | 363,70M |
| Total Liabilities | 201,92M | 188,57M | 200,50M | 134,76M | 125,14M |
| Shareholders' Equity | 67,83M | 138,18M | 117,74M | 185,40M | 238,56M |
| Total Debt | 84,80M | 89,26M | 92,25M | 23,73M | 22,25M |
| Cash & Equivalents | 103,66M | 129,57M | 115,52M | 137,70M | 209,52M |
| Current Assets | 123,52M | 159,62M | 154,34M | 183,24M | 272,58M |
| Current Liabilities | 60,78M | 67,08M | 82,07M | 68,13M | 54,15M |